Homocysteine and ischemic stroke subtype: a relationship study in Chinese patients
Related Experiment Video
Updated: Jun 21, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Yuetao Ma1, Xingquan Zhao, Wei Zhang
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.
Insights
Elevated homocysteine levels are linked to small vessel disease and leukoaraiosis severity in Chinese ischemic stroke patients. Those with confluent leukoaraiosis showed the highest homocysteine levels.
Area of Science:
- Neurology
- Vascular Medicine
- Biochemistry
Background:
- Elevated homocysteine is a known risk factor for ischemic stroke.
- Homocysteine is associated with small vessel disease, including confluent leukoaraiosis, in diverse populations.
- The relationship between homocysteine and stroke subtypes in the Chinese population requires further investigation.
Purpose of the Study:
- To investigate the association between total serum homocysteine levels and ischemic stroke subtypes in a Chinese population.
- To explore the correlation between homocysteine levels and the severity of leukoaraiosis.
- To determine if confluent leukoaraiosis is associated with higher homocysteine levels in small vessel disease patients.
Main Methods:
- Enrolled 377 acute ischemic stroke patients and 106 transient ischemic attack patients.
- Classified stroke subtypes using the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria.
- Graded leukoaraiosis severity and categorized small vessel disease patients based on confluent leukoaraiosis.
Main Results:
- Small vessel disease patients exhibited the highest homocysteine levels after adjusting for covariates.
- Homocysteine levels differed significantly between ischemic stroke and transient ischemic attack groups.
- Elevated homocysteine correlated with increased leukoaraiosis severity in stroke and small vessel disease patients.
- Small vessel disease patients with leukoaraiosis had significantly higher homocysteine than those without.
Conclusions:
- Small vessel disease patients with confluent leukoaraiosis demonstrated the highest homocysteine levels in this Chinese cohort.
- Homocysteine levels are significantly associated with leukoaraiosis severity in ischemic stroke.
- Findings highlight homocysteine as a potential biomarker for small vessel disease and stroke severity.
Objective:
Elevated homocysteine level is a risk factor for ischemic stroke and associated with small vessel disease such as confluent leukoaraiosis in white and black population. We investigated the relationship between the total serum homocysteine level and ischemic stroke subtypes in Chinese population.
Methods:
Three hundred and seventy-seven acute ischemic stroke and 106 transient ischemic attack patients were consecutively enrolled into this study. Demographic information and traditional risk factors were collected. Stroke subtypes were classified using the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. Leukoaraiosis was graded from 0 to 3 according to the severity. Small vessel disease patients were further categorized into two subgroups of having or without confluent leukoaraiosis.
Results:
The highest homocysteine level was found in small vessel disease patients after adjusting for age, gender, traditional vascular risk factors and renal function. Homocysteine level was significantly different between the ischemic stroke and transient ischemic attack groups. Elevated homocysteine level was significantly correlated with the severity of leukoaraiosis in all patients with stroke and small vessel disease. Small vessel disease patients with leukoaraiosis had significant higher homocysteine levels than those without leukoaraiosis.
Conclusions:
In this group of Chinese patients studied, small vessel disease patients with confluent leukoaraiosis had the highest homocysteine levels.
Related Concept Videos
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Stroke: Introduction and Types
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...